Michael Uhlin is a Chief Scientific Officer and co-founder of Desumo Biotechnologies, where they focus on the development of single-cell screening technologies aimed at improving outcomes in stem cell transplants. With a robust background in clinical immunology and years of experience in the hospital and healthcare industry, they have held various leadership roles, including at Karolinska University Hospital and Karolinska Institutet. Michael is currently advancing their academic credentials with a professorship in Clinical Immunology. They earned a Ph.D. in Infection Biology from Karolinska Institutet and possess a strong entrepreneurial spirit in the life sciences sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices